Purdue Pharma's Global Strategy: From US Crisis to Worldwide Epidemic
The opioid crisis had been something people had been watching for years and it's something that will continue for years, and I think that kind of goes back to a term in the congressional report that said, like opiophobia or a word like that, essentially trying to soothe prescribers, patients, policymakers, not to be afraid, and there is some semblance to that.
Picture this: Purdue Pharma, the infamous company behind OxyContin, sees its US market shrink as prescriptions plummet by over 40%. What do they do? They pivot and set their sights on the global stage. In this gripping episode of Cover2 Resources, hosts bring together Guardian reporter Chris McGreal and Daily Caller journalist Evie Fordham to dissect Purdue's international ambitions through their company, Mundipharma.
The conversation is framed by a past interview with LA Times journalist Harriett Ryan, who sheds light on the company's aggressive tactics to infiltrate medicine cabinets worldwide. You'll hear about the alarming report released by Congress members Katherine Clark and Hal Rodgers, which exposes Purdue's unsettling influence on the World Health Organization. The episode dives deep into how profit-driven motives can jeopardize patient safety, not just in the US but globally.
From the WHO's questionable opioid prescribing guidelines to the pharmaceutical industry's meddling with CDC recommendations, this episode unpacks it all. Whether you're concerned about the long-term effectiveness of opioids or the broader implications of Big Pharma's actions, this episode offers a raw and eye-opening exploration of a crisis that knows no borders.